Absolutely. I do not intend to give away any of our conclusions or the recommendations we are going to be making in that report. I am merely referring to evidence that was given in oral sessions or in the written evidence which is freely available.
It is frustrating that we are so far into the legislative process and yet some fundamental questions are still to be resolved. Of course, nothing could be more fundamental than the definition of “psychoactive substance” itself. Addressing that will be the first and most important task of the Public Bill Committee, and it will have to assess whether the definition currently proposed is preferable to that put forward by the ACMD.
A second fundamental problem was highlighted by the evidence provided by both Police Scotland and the Scottish Government on how the current definition of a “psychoactive substance” will require evidence from qualified experts with experience of working with NPSs in order to be able to identify the substance and prove its psychoactivity. Establishing that knowledge base against the background of the fast-paced evolution of psychoactive substances would be difficult, and a constant requirement for expert evidence in court would be very costly. Some of the contradictory reports from Ireland suggest similar problems, and again serious scrutiny of these issues is still required.
Perhaps the most important thing to say about this legislation—we have appreciated this during our inquiry—is, as another hon. Member said, that we cannot see this Bill as a silver bullet. Of far more significance will be the strategies that must be put in place to prevent harm through education and awareness raising, and to intervene where individuals are at risk—that includes the risk that some, but far from all, psychoactive substance users will move to controlled substances or to unregulated dealers. We also need to reduce harm. It is only fair to say that there is a huge distance to travel before we can say that this is being done as well as it must be done. Perhaps in Committee we will be able to consider making information on these matters an express part of the review requirement under clause 57.
In short, this Bill is not a silver bullet—indeed, we could shoot ourselves in the foot if we are not careful to get this right. If the Bill is scrutinised carefully and amended in the light of the evidence, it could be a useful first step in tackling the dangers that many Members
have spoken about and that are posed by new psychoactive substances, but the Government need to address the legitimate questions that have been asked tonight. They include questions about the definition, the problems with clause 8, the issue of purchasing for friends, the contradictory evidence from Ireland and the potential for displacement. I wish the Bill Committee well in sorting it all out.
10.53 pm